Uncategorised - Ataxia UK

Uncategorised

Alterity Therapeutics announces positive results from its phase 2 trial of the drug ATH434 in MSA

On January 30th 2025, the pharmaceutical company Alterity Therapeutics announced positive data from their phase 2 placebo-controlled trial in early-stage MSA. MSA is a progressive neurological condition leading to impaired

Alterity Therapeutics announces positive results from its phase 2 trial of the drug ATH434 in MSA Read More »

Scroll to Top